Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomized, Active-Controlled, Parallel-Group Clinical Trial to Study the Efficacy and Long-Term Safety of Mometasone Furoate/Formoterol Fumarate (MF/F, MK-0887A [SCH418131]), Compared With Mometasone Furoate (MF, MK-0887 [SCH032088]), in Children With Persistent Asthma

NCT02741271 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT02741271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02741271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomized, Active-Controlled, Parallel-Group Clinical Trial to Study the Efficacy and Long-Term Safety of Mometasone Furoate/Formoterol Fumarate (MF/F, MK-0887A [SCH418131]), Compared With Mometasone Furoate (MF, MK-0887 [SCH032088]), in Children With Persistent Asthma
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
May 11, 2016
Completion date
December 4, 2017
Enrollment
181 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma